| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |